Sun Pharmaceutical Industries Limited - Pengestrømsopgørelse (TTM)

Sun Pharmaceutical Industries Limited
IN ˙ NSEI ˙ INE044A01036
1.618,50 ₹ ↓ -61,35 (-3,65%)
2026-04-24
DEL PRIS
Pengestrømsopgørelse (TTM)

Sun Pharmaceutical Industries Limited Pengestrømsopgørelse viser ændringer i likviditetspositioner over tid. Pengestrømsopgørelsesdata inkluderer kontanter fra driftsaktiviteter (CFOP), kontanter fra investeringsaktiviteter og kontanter fra finansieringsaktiviteter.

Alle tal er gange 1,000,000 undtagen pr. andel enheder.

2021
09-30
2022
03-31
2022
09-30
2023
03-31
2023
09-30
2024
03-31
2024
09-30
2025
03-31
2025
09-30
Kontanter fra driftsaktiviteter 82.511 89.845 40.183 49.593 116.171 121.350 127.155 140.721 125.540
Ændring (%) 8,89 -55,28 23,42 134,25 4,46 4,78 10,67 -10,79
% af pengestrømmen 437,17 -509,10 -151,54 4.294,54 1.049,56 260,30 487,29 1.431,37 624,63
Kontanter fra investeringsaktiviteter -4.581 -57.247 -60.134 -79.437 -55.940 -6.902 -42.679 -53.062 -94.129
Ændring (%) 1.149,62 5,04 32,10 -29,58 -87,66 518,35 24,33 77,40
% af pengestrømmen -24,27 324,39 226,78 -6.878,84 -505,40 -14,81 -163,55 -539,73 -468,35
Kontanter fra finansieringsaktiviteter -59.277 -51.935 -8.978 23.761 -54.565 -67.102 -58.914 -79.058 -17.469
Ændring (%) -12,39 -82,71 -364,66 -329,65 22,97 -12,20 34,19 -77,90
% af pengestrømmen -314,07 294,28 33,86 2.057,56 -492,98 -143,94 -225,77 -804,16 -86,92
Cash Flow 18.874 -17.648 -26.516 1.155 11.068 46.619 26.094 9.831 20.098
Ændring (%) -193,50 50,25 -104,36 858,48 321,19 -44,03 -62,32 104,43
% af pengestrømmen 100,00 100,00 100,00 100,00 100,00 100,00 100,00 100,00 100,00

Source: Capital IQ

Other Listings
IN:524715 1.619,95 ₹
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista